Summary
- Current Price
- As of today, ABOS price is $2.83, up +1.80% on
- Current Price All-Time High
- ABOS price is currently -89.51% below its historical high of $26.98 set on
- Market Cap
- ABOS current market cap is $171M, up +119.43% over the past 365 days
- PE Ratio
- ABOS PE ratio is unknown
- Revenue
- ABOS current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for ABOS is on
Profile
| Metric | Value |
|---|---|
| Full Name | Acumen Pharmaceuticals, Inc. |
| Ticker | NASDAQ: ABOS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | acumenpharm.com |
| Employees | 61 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $2.83 | ||
| Price, 1D Change | +1.80% | |
| $171M | ||
| - | ||
| - | ||
| 1.14 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.71 | ||
| EPS, 1Y Change | -58.26% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.71 | ||
| EPS Estimate | -$2.28 | |
| EPS Est. Change | -33.99% | |
| $0.00 | ||
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| $2.83 | ||
| Price Target | - | $7.00 |
| Price Tgt. Change | - | +147.35% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.07 | -$1.08 | -0.69% | |
| -$1.32 | -$1.71 | -28.95% | |
| -$2.28 | N/A | -33.99% | |
| -$1.94 | N/A | -13.54% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +117.69% | ||
| -45.99% | ||
| +119.43% | ||
| -20.26% | ||
| 0.00% | ||
| 0.00% | ||
| -58.26% | ||
| +31.40% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $2.83 | ||
| $1.70 | ||
| SMA 200 vs Price | -39.86% | |
| $2.25 | ||
| SMA 50 vs Price | -20.48% | |
| 1.14 | ||
| $0.22 | ||
| 64.04 | ||
| 75.95% | ||
| 89.51% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$1.71 | ||
| -$178.00K | ||
| - | ||
| -$114.02M | ||
| - | ||
| -$102.33M | ||
| - | ||
| -$98.08M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.16 | ||
| 6.46 | ||
| 6.46 | ||
| - | ||
| - | ||
| -0.71 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 1.84 | ||
| -0.55 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $181.82M | ||
| $35.63M | ||
| $238.99M | ||
| $178.31M | ||
| $57.18M | ||
| $27.61M | ||
| $29.70M | ||
| $133.00K | ||
| $5.65M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $114.02M | ||
| $114.02M | ||
| $178.00K | ||
| $20.22M | ||
| $178.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$86.22M | ||
| $48.03M | ||
| $6.93M | ||
| $16.00K | ||
| -$86.23M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| BTIG | → | |
| B of A Securities | → | |
| B of A Securities | → | |
| Citigroup | ||
| UBS | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| UBS | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with ABOS
FAQ
What is the ticker symbol for Acumen Pharmaceuticals, Inc.?
The ticker symbol for Acumen Pharmaceuticals, Inc. is NASDAQ:ABOS
Does Acumen Pharmaceuticals, Inc. pay dividends?
No, Acumen Pharmaceuticals, Inc. does not pay dividends
What sector is Acumen Pharmaceuticals, Inc. in?
Acumen Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Acumen Pharmaceuticals, Inc. in?
Acumen Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Acumen Pharmaceuticals, Inc. based in?
Acumen Pharmaceuticals, Inc. is headquartered in United States
When did Acumen Pharmaceuticals, Inc. go public?
Acumen Pharmaceuticals, Inc. initial public offering (IPO) was on July 1, 2021
Is Acumen Pharmaceuticals, Inc. in the S&P 500?
No, Acumen Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Acumen Pharmaceuticals, Inc. in the NASDAQ 100?
No, Acumen Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Acumen Pharmaceuticals, Inc. in the Dow Jones?
No, Acumen Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Acumen Pharmaceuticals, Inc. last earnings report?
Acumen Pharmaceuticals, Inc.'s most recent earnings report was on November 12, 2025
When does Acumen Pharmaceuticals, Inc. report earnings?
The next expected earnings date for Acumen Pharmaceuticals, Inc. is March 24, 2026
Data Sources & References
- ABOS Official Website acumenpharm.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1576885/000157688525000104/0001576885-25-000104-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1576885/000157688525000049/0001576885-25-000049-index.htm
- ABOS Profile on Yahoo Finance finance.yahoo.com/quote/ABOS
- ABOS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/abos